Insufficient scRNA-seq data for expression of PRG3 at single-cell level.
Insufficient scRNA-seq data for expression of PRG3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 76% | 55.06 | 183 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 57% | 747.56 | 530 / 929 | 0% | 0 | 0 / 0 |
| lung | 31% | 15.25 | 182 / 578 | 0% | 0.01 | 3 / 1155 |
| liver | 6% | 0.72 | 14 / 226 | 0% | 0 | 0 / 406 |
| adipose | 4% | 0.71 | 45 / 1204 | 0% | 0 | 0 / 0 |
| breast | 3% | 0.72 | 14 / 459 | 0% | 0.00 | 2 / 1118 |
| adrenal gland | 2% | 0.22 | 5 / 258 | 1% | 0.01 | 2 / 230 |
| heart | 3% | 0.49 | 22 / 861 | 0% | 0 | 0 / 0 |
| stomach | 0% | 0.02 | 1 / 359 | 2% | 0.03 | 5 / 286 |
| thymus | 2% | 0.25 | 12 / 653 | 0% | 0 | 0 / 605 |
| blood vessel | 1% | 0.24 | 19 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 1% | 0.08 | 5 / 966 | 1% | 0.02 | 4 / 527 |
| esophagus | 1% | 0.07 | 10 / 1445 | 1% | 0.01 | 1 / 183 |
| muscle | 1% | 0.33 | 8 / 803 | 0% | 0 | 0 / 0 |
| brain | 1% | 0.11 | 20 / 2642 | 0% | 0.00 | 1 / 705 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.04 | 6 / 901 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0.00 | 1 / 504 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| skin | 0% | 0 | 0 / 1809 | 0% | 0 | 0 / 472 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| uterus | 0% | 0 | 0 / 170 | 0% | 0 | 0 / 459 |
| GO_0006955 | Biological process | immune response |
| GO_0019370 | Biological process | leukotriene biosynthetic process |
| GO_0017148 | Biological process | negative regulation of translation |
| GO_0045575 | Biological process | basophil activation |
| GO_0001694 | Biological process | histamine biosynthetic process |
| GO_0042119 | Biological process | neutrophil activation |
| GO_0042554 | Biological process | superoxide anion generation |
| GO_0032757 | Biological process | positive regulation of interleukin-8 production |
| GO_1904724 | Cellular component | tertiary granule lumen |
| GO_0035580 | Cellular component | specific granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
| GO_0030246 | Molecular function | carbohydrate binding |
| Gene name | PRG3 |
| Protein name | Proteoglycan 3 (Eosinophil major basic protein homolog) (Prepro-major basic protein homolog) (Prepro-MBPH) |
| Synonyms | MBPH UNQ486/PRO1002 |
| Description | FUNCTION: Possesses similar cytotoxic and cytostimulatory activities to PRG2/MBP. In vitro, stimulates neutrophil superoxide production and IL8 release, and histamine and leukotriene C4 release from basophils. . |
| Accessions | ENST00000287143.2 Q9Y2Y8 |